| 英文别名 |
2',3',5'-Tri-O-acetyl-D-adenosine;2’,3’,5’-Tri-O-acetyladenosine;(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate;2',3',5'-TRI-O-ACETYLADENOSINE;2’,3’,5’-Tri-O-acety;2,3,5-TRIACETYLADENOSINE;Tri-O-acetyladenosine;NSC 76766;[3,4-diacetoxy-5-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methyl acetate;[3,4-diacetoxy-5-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methyl acetate;7387-57-7;7387-57-7;A51106;A51106;AKOS004903253;AKOS004903253;J-700360;J-700360;Adenosine, 2',3',5'-triacetate;Adenosine, 2',3',5'-triacetate;DS-8003;DS-8003;AC-32263;AC-32263;2?,3?,5?-Tri-O-acetyladenosine;(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate;2?,3?,5?-Tri-O-acetyladenosine;(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate;C16H19N5O7;[(2R,3R,4R,5R)-3,4-bis(acetyloxy)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl]methyl acetate;C16H19N5O7;2',3',5'-Tri-O-acetyladenosine, >=98%;[(2R,3R,4R,5R)-3,4-bis(acetyloxy)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl]methyl acetate;2',3',5'-Tri-O-acetyladenosine;GCVZNVTXNUTBFB-XNIJJKJLSA-N;2',3',5'-Tri-O-acetyladenosine, >=98%;[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl acetate;2',3',5'-Tri-O-acetyladenosine;(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyldiacetate;GCVZNVTXNUTBFB-XNIJJKJLSA-N;SCHEMBL4425824;[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl acetate;2',3',5'-TRI-O-Acetyadenosine;(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyldiacetate;MFCD00057001;SCHEMBL4425824;A837949;2',3',5'-TRI-O-Acetyadenosine;2',3',5'-Tri-O-acetyl adenosine;MFCD00057001;Adenosine 2',3',5'-Triacetate;A837949;2',3',5'-Tri-O-acetyl;2',3',5'-Tri-O-acetyl adenosine;Adenosine 2',3',5'-Triacetate;2',3',5'-Tri-O-acetyl |
微信公众号
客服
